Matthew B. Harms

8.8k citations

33 papers · 3.2k indexed · 3 hit papers · h-index 24

Neurology top 0.5%
- Amyotrophic Lateral Sclerosis Research 16
- Parkinson's Disease Mechanisms and Treatments 5
- Neurological diseases and metabolism 4
Genetics top 0.5%
- Neurogenetic and Muscular Disorders Research 16
Neurology top 1%
- Amyotrophic Lateral Sclerosis Research 16
- Parkinson's Disease Mechanisms and Treatments 5
- Neurological diseases and metabolism 4
Cellular and Molecular Neuroscience top 2%
- Genetic Neurodegenerative Diseases 6
Molecular Biology top 5%
- Muscle Physiology and Disorders 5
- RNA Research and Splicing 4
Epidemiology
- Autophagy in Disease and Therapy 4

Co-authors: Robert H. Baloh Alan Pestronk Timothy M. Miller John Ravits Peggy Allred Shaughn Bell Craig M. Zaidman Jacqueline G. O’Rourke
Cited by: Neurology Genetics
Journals: Science (1 paper)Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (1 paper)
Partner nations: United States Australia Canada

In The Last Decade

Matthew B. Harms

31 papers receiving 3.2k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2016 Science
2013 Science Translational Medicine
2013 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by Matthew B. Harms

Since Specialization

Citations

This map shows the geographic impact of Matthew B. Harms's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew B. Harms with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew B. Harms more than expected).

Fields of papers citing papers by Matthew B. Harms

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew B. Harms. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew B. Harms. The network helps show where Matthew B. Harms may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Matthew B. Harms, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Matthew B. Harms Line = papers co-authored together Matthew B. Harms links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Body mass index is lower in asymptomatic C9orf72 expansion carriers but not in SOD1 pathogenic variant carriers compared to gene negatives Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration ·Ik Jae Lee,Mark A. Garret,Joanne Wuu,Elizabeth A. Harrington,James D. Berry,Timothy M. Miller,Matthew B. Harms,Michael Benatar,Neil A. Shneider	2024	0
2	Evidence‐based consensus guidelines for ALS genetic testing and counseling Annals of Clinical and Translational Neurology ·Jennifer Roggenbuck,Breda Eubank,Joshua D. Wright,Matthew B. Harms,Stephen J. Kolb,(unknown)	2023	24
3	Precision genetic cellular models identify therapies protective against ER stress Cell Death and Disease ·Irina V. Lebedeva,Michelle V. Wagner,Sunil Sahdeo,Yifan Lu,Anuli Anyanwu‐Ofili,Matthew B. Harms,Jehangir S. Wadia,G. Rajagopal,Michael J. Boland,David B. Goldstein	2021	8
4	Primary lateral sclerosis: consensus diagnostic criteria Journal of Neurology Neurosurgery & Psychiatry ·Martin R. Turner,Richard J. Barohn,Philippe Corcia,John K. Fink,Matthew B. Harms,Matthew C. Kiernan,John Ravits,Vincenzo Silani,Zachary Simmons,Jeffrey Statland,Leonard H. van den Berg,Hiroshi Mitsumoto,(unknown)	2020	125
5	A new approach for rare variation collapsing on functional protein domains implicates specific genic regions in ALS Genome Research ·Sahar Gelfman,Sarah A. Dugger,Cristiane Araújo Martins Moreno,Zhong Ren,Charles J. Wolock,Neil A. Shneider,Hemali Phatnani,Elizabeth T. Cirulli,Brittany N. Lasseigne,Tim Harris,Tom Maniatis,Guy A. Rouleau,Robert H. Brown,Aaron D. Gitler,R Myers,Slavé Petrovski,Andrew S. Allen,David B. Goldstein,Matthew B. Harms	2019	14
6	Homozygous recessive MYH2 mutation mimicking dominant MYH2 associated myopathy Neuromuscular Disorders ·Andrew R. Findlay,Matthew B. Harms,Alan Pestronk,Conrad C. Weihl	2018	9
7	C9orf72 is required for proper macrophage and microglial function in micebreakdown → Science ·Jacqueline G. O’Rourke,Laurent Bogdanik,Alberto Yáñez,Deepti Lall,Andrea J. Wolf,A.K.M. Ghulam Muhammad,Ritchie Ho,Sharon Carmona,Jean‐Philippe Vit,Jonah E. Zarrow,Ki Jung Kim,Shaughn Bell,Matthew B. Harms,Timothy M. Miller,Charles A. Dangler,David M. Underhill,Helen S. Goodridge,Cathleen Lutz,Robert H. Baloh	2016	400
8	Targeted sequencing and identification of genetic variants in sporadic inclusion body myositis Neuromuscular Disorders ·Conrad C. Weihl,Robert H. Baloh,Youjin Lee,Tsui‐Fen Chou,Sara K. Pittman,Glenn Lopate,Peggy Allred,Jennifer Jockel‐Balsarotti,Alan Pestronk,Matthew B. Harms	2015	49
9	LIMS2 mutations are associated with a novel muscular dystrophy, severe cardiomyopathy and triangular tongues Clinical Genetics ·Jodi Warman‐Chardon,Amanda Smith,John Woulfe,Elena Peña,Kawan Rakhra,Carole Dennie,Chandree L. Beaulieu,Lijia Huang,Jeremy Schwartzentruber,Cynthia Hawkins,Matthew B. Harms,Sue Dojeiji,M. Zhang,Jacek Majewski,Dennis E. Bulman,Kym M. Boycott,David A. Dyment	2015	15
10	Mutation screen reveals novel variants and expands the phenotypes associated with DYNC1H1 Journal of Neurology ·Alleene V. Strickland,Maria Schabhüttl,H. Offenbacher,Matthis Synofzik,Natalie Hauser,Michaela Brunner‐Krainz,U Gruber‐Sedlmayr,Steven A. Moore,Reinhard Windhager,Benjamin Bender,Matthew B. Harms,Stephan Klebe,Peter Young,Marina Kennerson,Avencia Sanchez Mejias Garcia,Michael Gonzalez,Stephan Züchner,Rebecca Schüle,Michael E. Shy,Michaela Auer‐Grumbach	2015	49
11	Hypermethylation of repeat expanded C9orf72 is a clinical and molecular disease modifier Acta Neuropathologica ·Jenny Russ,Elaine Y. Liu,Kathryn Wu,Donald Neal,EunRan Suh,David J. Irwin,Corey T. McMillan,Matthew B. Harms,Nigel J. Cairns,Elisabeth McCarty Wood,Sharon X. Xie,Lauren Elman,Leo McCluskey,Murray Grossman,Vivianna M. Van Deerlin,Edward B. Lee	2014	90
12	Autophagic vacuolar pathology in desminopathies Neuromuscular Disorders ·Conrad C. Weihl,Stanley Iyadurai,Robert H. Baloh,Sara K. Pittman,Robert E. Schmidt,Glenn Lopate,Alan Pestronk,Matthew B. Harms	2014	20
13	Rare variants in FBN1 and FBN2 are associated with severe adolescent idiopathic scoliosis Human Molecular Genetics ·Jillian G. Buchan,David M. Alvarado,Gabe Haller,Carlos Cruchaga,Matthew B. Harms,Tianxiao Zhang,Marcia Willing,Dorothy K. Grange,Alan C. Braverman,Nancy H. Miller,José A. Morcuende,Nelson L.S. Tang,Tsz Ping Lam,Bobby K. W. Ng,Jack C. Y. Cheng,Matthew B. Dobbs,Christina A. Gurnett	2014	83
14	Ultrasound of inherited vs. acquired demyelinating polyneuropathies Journal of Neurology ·Craig M. Zaidman,Matthew B. Harms,Alan Pestronk	2013	112
15	Dynein mutations associated with hereditary motor neuropathies impair mitochondrial morphology and function with age Neurobiology of Disease ·Judith Eschbach,Jérôme Sinniger,Jamal Bouitbir,Anissa Fergani,Anna-Isabel Schlagowski,Joffrey Zoll,Bernard Gény,Frédérique René,Yves Larmet,Vincent Marion,Robert H. Baloh,Matthew B. Harms,Michael E. Shy,Nadia Messadeq,Patrick Weydt,Jean‐Philippe Loeffler,Albert C. Ludolph,Luc Dupuis	2013	41
16	Clinical Neurogenetics Neurologic Clinics ·Matthew B. Harms,Robert H. Baloh	2013	24
17	Targeting RNA Foci in iPSC-Derived Motor Neurons from ALS Patients with a C9ORF72 Repeat Expansionbreakdown → Science Translational Medicine ·Dhruv Sareen,Jacqueline G. O’Rourke,Pratap Meera,A.K.M. Ghulam Muhammad,Sharday Grant,Megan Simpkinson,Shaughn Bell,Sharon Carmona,Loren Ornelas,Anais Sahabian,Tania F. Gendron,Leonard Petrucelli,Michael W. Baughn,John Ravits,Matthew B. Harms,Frank Rigo,C. Frank Bennett,Thomas S. Otis,Clive N. Svendsen,Robert H. Baloh	2013	493
18	Lack of C9ORF72 coding mutations supports a gain of function for repeat expansions in amyotrophic lateral sclerosis Neurobiology of Aging ·Matthew B. Harms,Janet Cady,Craig M. Zaidman,Paul Cooper,Taha Bali,Peggy Allred,Carlos Cruchaga,Michael W. Baughn,Ryan T. Libby,Alan Pestronk,Alison Goate,John Ravits,Robert H. Baloh	2013	58
19	Parkinson disease is not associated with C9ORF72 repeat expansions Neurobiology of Aging ·Matthew B. Harms,Drexel A. Neumann,Bruno A. Benítez,Breanna Cooper,David Carrell,Brad A. Racette,Joel S. Perlmutter,Alison Goate,Carlos Cruchaga	2012	33
20	Exome sequencing reveals DNAJB6 mutations in dominantly‐inherited myopathy Annals of Neurology ·Matthew B. Harms,R. Brian Sommerville,Peggy Allred,Shaughn Bell,Duanduan Ma,Paul R. Cooper,Glenn Lopate,Alan Pestronk,Conrad C. Weihl,Robert H. Baloh	2011	124

About Matthew B. Harms

Matthew B. Harms is a scholar working on Genetics, Neurology and Neurology, having authored 33 papers that have together received 3.2k indexed citations. Recurring topics across this work include Neurogenetic and Muscular Disorders Research (16 papers), Amyotrophic Lateral Sclerosis Research (16 papers), Genetic Neurodegenerative Diseases (6 papers), Muscle Physiology and Disorders (5 papers), Parkinson's Disease Mechanisms and Treatments (5 papers), Neurological diseases and metabolism (4 papers), Autophagy in Disease and Therapy (4 papers) and RNA Research and Splicing (4 papers). The work is most often cited by research in Neurology (1.8k citations), Genetics (1.1k citations) and Neurology (611 citations). Matthew B. Harms has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Robert H. Baloh, Alan Pestronk, Timothy M. Miller, John Ravits, Peggy Allred, Shaughn Bell, Craig M. Zaidman, Jacqueline G. O’Rourke, Sharon Carmona and A.K.M. Ghulam Muhammad. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact